PT  - JOURNAL ARTICLE
AU  - Roopa Kalyanaraman Marcello
AU  - Johanna Dolle
AU  - Areeba Tariq
AU  - Sharanjit Kaur
AU  - Linda Wong
AU  - Joan Curcio
AU  - Rosy Thachil
AU  - Stella S. Yi
AU  - Nadia Islam
TI  - Disaggregating Asian Race Reveals COVID-19 Disparities among Asian Americans at New York City’s Public Hospital System
AID  - 10.1101/2020.11.23.20233155
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.23.20233155
4099  - http://medrxiv.org/content/early/2020/11/24/2020.11.23.20233155.short
4100  - http://medrxiv.org/content/early/2020/11/24/2020.11.23.20233155.full
AB  - There is growing recognition of the burden of COVID-19 among Asian Americans, but data on outcomes among Asian ethnic subgroups remain extremely limited. We conducted a retrospective analysis of 85,328 patients tested for COVID-19 at New York City’s public hospital system between March 1 and May 31, 2020, to describe characteristics and COVID-19 outcomes of Asian ethnic subgroups compared to Asians overall and other racial/ethnic groups. South Asians had the highest rates of positivity and hospitalization among Asians, second only to Hispanics for positivity and Blacks for hospitalization. Chinese patients had the highest mortality rate of all groups and were nearly 1.5 times more likely to die than Whites. The high burden of COVID-19 among South Asian and Chinese Americans underscores the urgent needs for improved data collection and reporting as well as public health program and policy efforts to mitigate the disparate impact of COVID-19 among these communities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Biomedical Research Alliance of New York Institutional Review Board. Informed consent was not required because of the retrospective nature of this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be made available upon request.